Nuwellis Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Nuwellis Inc trades at $1.48 (market cap $542.80K), while ABRDN Physical Gold Shares ETF trades at $42.02. The key difference: ABRDN Physical Gold Shares ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SGOL | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $220.50 | $51.41 |
52-Week Low | $1.42 | $31.61 |
Enterprise Value | -$1.27M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
SGOL, a US-listed gold ETF, trades at $41.35, up 2.22% today, with a bullish technical signal from moving averages but overbought RSI readings. Recent news highlights gold's rebound potential, driven by central bank buying and dovish Fed expectations. The stock shows strong support at $41 and resistance at $42, with institutional sentiment leaning positive amid macroeconomic support for precious metals.
Outlook remains cautiously optimistic as gold benefits from lower real yields and geopolitical factors, though overbought conditions near-term pose a risk. Investment appeal hinges on sustained macroeconomic trends, while volatility from dollar movements and profit-taking presents challenges for short-term holders.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →